Search results for "GI bleeding"


 
Results 11 - 20 of about 46 for "GI bleeding".
Sort by: Relevance | Newest | Oldest

Endoscopic spray device approved to be marketed to treat GI bleeding

The device delivers a mineral blend to sites of upper or lower GI bleeding and is applied during an endoscopic procedure.
https://gastroenterology.acponline.org/archives/2018/05/25/7.htm
25 May 2018

Bentonite hemostatic powder noninferior to standard care for GI bleeding

In a single-blind randomized controlled trial, bleeding was controlled within 30 days in 90.1% of adults with acute nonvariceal bleeding on upper GI endoscopy assigned to receive TC-325 versus 81.4% of those assigned to standard treatment.
https://gastroenterology.acponline.org/archives/2021/12/17/3.htm
17 Dec 2021

GI bleeding prophylaxis recommended in high-risk critically ill patients

Proton-pump inhibitors appeared to reduce bleeding risk more than histamine-2 receptor antagonists.
https://gastroenterology.acponline.org/archives/2020/01/24/9.htm
24 Jan 2020

Scores to predict outcomes of upper GI bleeding compared

Researchers calculated three pre-endoscopy scores—admission Rockall, AIMS65, and Glasgow Blatchford—and two postendoscopy scores—full Rockall and PNED.
https://gastroenterology.acponline.org/archives/2017/01/27/4.htm
27 Jan 2017

Clinical prediction model may help determine management for acute lower GI bleeding

Factors associated with safe discharge in the development and validation cohorts were age, female sex, no previous admission for lower GI bleeding, no blood on digital rectal exam, heart rate, systolic blood pressure, and hemoglobin level.
https://gastroenterology.acponline.org/archives/2017/07/28/3.htm
28 Jul 2017

GI bleeding risks with warfarin and DOACs compared

Warfarin was associated with a similar risk of lower GI bleeding as direct oral anticoagulants (DOACs) but more than twice the rate of upper GI bleeding, which led study authors to suggest that DOACs may be preferable to warfarin in patients at high risk of upper GI bleeds.
https://gastroenterology.acponline.org/archives/2022/08/26/1.htm
26 Aug 2022

In adults with severe acute GI bleeding, tranexamic acid did not reduce death due to bleeding at 5 days

Based on findings from a randomized trial, tranexamic acid is unlikely to confer additional benefit beyond the current standard of care in all patients with severe upper or lower GI bleeding, an ACP Journal Club commentary said.
https://gastroenterology.acponline.org/archives/2020/10/23/10.htm
23 Oct 2020

Daily aspirin for primary CVD prevention increased risk for major GI bleeding in healthy older adults

While aspirin is not recommended for primary prevention of cardiovascular disease (CVD) in most adults ages 70 years and older, more research is needed to assess its role in select high-risk populations of older adults, an ACP Journal Club commentary said.
https://gastroenterology.acponline.org/archives/2021/01/22/6.htm
22 Jan 2021

GI bleeding less common in U.S. veterans on NOACs than those on warfarin

Significant bleeding occurred in 2.5% of the patients on warfarin and 0.6% of the patients on non-vitamin K antagonist oral anticoagulants (NOACs).
https://gastroenterology.acponline.org/archives/2017/03/24/3.htm
24 Mar 2017

Rivaroxaban associated with increased risk for GI bleeding compared to other DOACs

A study in Iceland of direct oral anticoagulants (DOACs) found a higher risk for overall and major GI bleeding with rivaroxaban than with either apixaban or dabigatran.
https://gastroenterology.acponline.org/archives/2021/10/22/1.htm
22 Oct 2021

Result Page: Prev   1   2   3   4   5   Next